Core Viewpoint - Hai Xin Co., Ltd. reported a slight decline in revenue for the first three quarters of 2025, while net profit showed a positive growth trend [1] Financial Performance - The company achieved a revenue of 598 million yuan, representing a year-on-year decrease of 1.29% [1] - The net profit attributable to shareholders reached 144 million yuan, marking a year-on-year increase of 3.83% [1] - The non-recurring net profit was 139 million yuan, which is a year-on-year growth of 3.68% [1] - Basic earnings per share stood at 0.1193 yuan [1]

Core Viewpoint - Hai Xin Co., Ltd. reported a year-on-year increase in revenue for the third quarter, but a decline in net profit attributable to shareholders [1] Financial Performance - The company achieved an operating revenue of 225 million yuan in the third quarter, representing a year-on-year growth of 13.12% [1] - The net profit attributable to shareholders was 36.48 million yuan, showing a year-on-year decrease of 1.12% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 34.28 million yuan, down 0.62% year-on-year [1] - Basic earnings per share were reported at 0.0302 yuan [1]

Financial Performance - The company's operating revenue for the third quarter was CNY 224,995,784.75, an increase of 13.12% compared to the same period last year[4] - The total profit for the quarter was CNY 46,098,878.36, reflecting a slight increase of 0.17% year-over-year[4] - The net profit attributable to shareholders was CNY 36,477,804.26, showing a decrease of 1.12% compared to the previous year[4] - The company reported a net profit excluding non-recurring gains and losses of CNY 34,277,020.62, a decrease of 0.62% year-over-year[4] - Total operating revenue for the first three quarters of 2025 was CNY 597.57 million, a decrease of 1.37% compared to CNY 605.40 million in the same period of 2024[19] - Net profit for the first three quarters of 2025 increased to CNY 158.92 million, up 4.93% from CNY 151.97 million in 2024[20] - The company reported a total comprehensive income of CNY 243.31 million, down from CNY 494.17 million in the same period last year[20] Cash Flow - The cash flow from operating activities for the quarter was CNY 6,435,250.20, a significant increase of 124.39% year-over-year[5] - Cash flow from operating activities generated a net amount of CNY 89.88 million, significantly higher than CNY 40.25 million in the same period last year[23] - Cash flow from investing activities showed a net outflow of CNY 183.07 million, worsening from a net outflow of CNY 42.40 million in 2024[24] - Cash flow from financing activities resulted in a net inflow of CNY 10.84 million, compared to a net outflow of CNY 99.58 million in the previous year[24] Assets and Liabilities - The total assets at the end of the reporting period amounted to CNY 5,829,091,579.26, representing a growth of 9.34% from the end of the previous year[5] - The company's total liabilities reached RMB 985,742,430.20, up from RMB 830,429,687.17, indicating an increase of about 18.7%[17] - The company's non-current liabilities increased to RMB 688,948,025.41 from RMB 531,398,107.40, indicating a rise of about 29.6%[17] - The company reported a total current asset of RMB 1,360,091,294.29, up from RMB 985,359,152.06, reflecting a growth of about 38%[15] Equity - The total equity attributable to shareholders increased to CNY 4,669,636,468.97, up by 7.74% from the previous year[5] - The total equity attributable to shareholders increased to RMB 4,669,636,468.97 from RMB 4,334,362,916.97, representing a growth of approximately 7.7%[17] - The company's retained earnings grew to RMB 1,119,530,779.68 from RMB 868,646,876.56, representing an increase of approximately 28.8%[17] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 60,040, with the top ten shareholders holding a combined 41.67% of the shares[10] Other Financial Metrics - The weighted average return on equity decreased to 0.8296%, down by 0.0957 percentage points compared to the previous year[5] - Basic and diluted earnings per share rose to CNY 0.1193, compared to CNY 0.1149 in the previous year[20] - The company’s tax expenses for the first three quarters of 2025 were CNY 9.14 million, slightly lower than CNY 9.30 million in 2024[20] - Other comprehensive income after tax for the first three quarters of 2025 was CNY 84.39 million, a significant decrease from CNY 342.21 million in the previous year[20] - The company received government subsidies amounting to CNY 545,039.63 during the quarter, which are closely related to its normal business operations[7] Asset Composition - Cash and cash equivalents decreased to RMB 377,162,613.97 from RMB 489,446,527.98, a decline of about 23%[15] - The company's trading financial assets surged to RMB 750,002,561.90 from RMB 280,185,435.70, marking an increase of approximately 167%[15] - Accounts receivable rose to RMB 93,379,783.71 from RMB 85,948,274.37, reflecting an increase of about 8.3%[15] - Inventory decreased to RMB 49,425,394.22 from RMB 71,801,633.85, a decline of approximately 31%[15]

Core Points - The Shanghai Composite Index is currently at 3993.52 points, slightly below the half-year line with a change of -0.09% [1] - A total of 66 A-shares have surpassed the half-year line today, with notable stocks showing significant deviation rates [1] Group 1: Stock Performance - The stock with the highest deviation rate is Libang Instruments, with a deviation rate of 14.95% and a daily increase of 16.28% [1] - Tax Friend Co. and Founder Motor follow with deviation rates of 6.81% and 6.27%, respectively, both showing daily increases of 10.00% and 9.98% [1] - Other notable stocks include Cuihua Jewelry and Furuite Equipment, with deviation rates of 4.94% and 4.50% respectively [1] Group 2: Trading Volume and Market Activity - The total trading volume of A-shares today reached 10089.87 billion yuan [1] - The turnover rate for Tax Friend Co. is notably high at 46.64%, indicating strong trading activity [1] - Other stocks with significant turnover rates include Libang Instruments at 10.82% and Cuihua Jewelry at 8.21% [1]

Core Insights - Hai Xin Co., Ltd. (600851) reported a net financing purchase of 2.4693 million yuan on October 27, 2025, with a financing balance of 203 million yuan, indicating a continuous net purchase over the last three trading days totaling 7.7309 million yuan [1][2][3] Financing Activity Summary - On October 27, 2025, the net financing purchase was 2.4693 million yuan, with a financing balance of 203 million yuan, representing 4.11% of the circulating market value [2] - The financing balance increased by 1.23% from the previous day, reflecting a net increase of 2.4693 million yuan [3] - Over the past 20 trading days, there were 11 days with net financing purchases, indicating a trend of increasing investor interest [1] Historical Financing Data - The financing balance on October 24, 2025, was 201 million yuan, with a net purchase of 3.2831 million yuan, showing a 1.66% increase [3] - On October 23, 2025, the financing balance was 198 million yuan, with a net purchase of 1.9785 million yuan, marking a 1.01% increase [3] - The financing balance on October 21, 2025, was 194 million yuan, with a net outflow of 3.3822 million yuan, indicating a decrease of 1.71% [3]

Core Viewpoint - The company has approved a strategic plan for 2026-2030 to adapt to macroeconomic changes and technological transformations, aiming to strengthen its market position and drive growth [1][2]. Group 1: Board Meeting Details - The board meeting was held on October 15, 2025, in Shanghai, with all 9 directors present, including participation via communication methods [1]. - The meeting was chaired by Chairman Deng Haibin, with all senior executives in attendance [1]. Group 2: Strategic Planning - The strategic plan focuses on two main growth curves: enhancing the existing pharmaceutical business through management improvements and acquisitions, and exploring new opportunities for innovation and development [2]. - The property management sector will continue to operate steadily, contributing stable cash profits to support both growth curves [2]. - The company aims to achieve high-quality development and continuous value growth through a dual strategy of "industrial operation + investment and mergers" [2].

Group 1 - The board of directors of Shanghai Haixin Group Co., Ltd. held its 13th meeting of the 11th session on October 15, 2025, in accordance with relevant laws and regulations [2][3] - The meeting was attended by all 9 directors, with some participating via communication methods [2] - The board unanimously approved the strategic plan for 2026-2030, focusing on strengthening the company's core business and exploring new growth opportunities through mergers and acquisitions [3] Group 2 - The strategic plan aims to adapt to macroeconomic changes and industry transformations while enhancing the company's operational capabilities [3] - The company will pursue a dual strategy of "industrial operation + investment and mergers" to drive innovation and high-quality development [3] - The property management sector is expected to continue providing stable cash flow to support the company's growth initiatives [3]

Group 1 - Company held its 13th meeting of the 11th board of directors on October 15, 2025, in Shanghai, discussing strategic planning documents [1] - For the year 2024, the revenue composition of the company is as follows: pharmaceutical manufacturing accounts for 54.76%, trading business for 17.33%, textile industry for 14.83%, and other businesses for 13.08% [1] - The current market capitalization of the company is 8.1 billion yuan [2]

一、董事会会议召开情况 （一）本次董事会会议的召开符合有关法律、行政法规、部门规章、规范性 文件和公司章程的规定； （二）本次董事会会议通知于 2025 年 9 月 29 日以书面方式向全体董事发出， 会议资料于同日以书面方式向全体董事发出； 证券代码：600851/900917 证券简称：海欣股份/海欣B股 公告编号：2025-032 上海海欣集团股份有限公司 第十一届董事会第十三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 为积极应对国内外宏观环境变化、产业变迁与技术变革的发展趋势，把握新 时代重要战略机遇，上海海欣集团股份有限公司（以下简称公司）以做优做强上 1 市公司为基本目标，制定了《上海海欣集团股份有限公司战略规划（2026 年—2030 年）》，全面规划公司未来五年的发展方向与目标。 未来五年，公司将秉持稳中求进的总基调，强化产业运营和投资并购，在战 略选择上，一方面，坚持从实际出发，依托已有的医药产业基础持续深耕，通过 内强管理、深挖潜能和外延并购扩张，推动资源整合和业务升级，努力做大做强 ...

Group 1 - The company has approved an investment of up to 30 million RMB in the Yuanhe Puhua Industrial M&A Fund, considering the fund's risk diversification and the management's strong investment capabilities [2][3] - The company, along with its wholly-owned subsidiary, has committed 30 million RMB to the fund, becoming a limited partner in the partnership [2] - The partnership has successfully raised a total of 2.473 billion RMB for the fund, with the partnership term extended from eight years to ten years [4][5] Group 2 - The fund has completed the necessary registration and filing with the China Securities Investment Fund Industry Association, with a registration date of September 27, 2024, and a change date of October 9, 2025 [5] - The fund is managed by Yuanhe Puhua Tongxin (Suzhou) Investment Management Co., Ltd., and the custodian is Industrial and Commercial Bank of China [5]